ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
42 906,95
0,00%
DAX
19 848,77
-0,34%
Brent Oil
73,255
0,76%
Bitcoin
96 203,05
1,59%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. Cotinga Pharmaceuticals Inc (COT)

  7. Cotinga Pharmaceuticals Inc (COT) Actualités

COT

Cotinga Pharmaceuticals (COT)

Cotinga Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:COT
DateHeureSourceTitreSymboleSociété
15/10/202014h01PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - COTTSXV:COTCotinga Pharmaceuticals Inc
15/10/202013h55PR Newswire (Canada)IIROC Trading Halt - COTTSXV:COTCotinga Pharmaceuticals Inc
07/11/201922h10PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - COTTSXV:COTCotinga Pharmaceuticals Inc
07/11/201922h09PR Newswire (Canada)IIROC Trading Resumption - COTTSXV:COTCotinga Pharmaceuticals Inc
24/07/201422h20Marketwired CanadaCritical Outcome Technologies Reports Year-End Financial and Operating ResultsTSXV:COTCotinga Pharmaceuticals Inc
23/06/201415h00MarketwiredCritical Outcome Technologies Seeks to Redefine Personalized Cancer Care With Project ROSALINDTSXV:COTCotinga Pharmaceuticals Inc
17/06/201415h00MarketwiredCritical Outcome Technologies Receives Orphan Drug Designation For COTI-2TSXV:COTCotinga Pharmaceuticals Inc
16/06/201415h00Marketwired CanadaCritical Outcome Technologies to Commence Trading in U.S. on OTCQB Under Symbol COTQFTSXV:COTCotinga Pharmaceuticals Inc
14/06/201401h42Marketwired CanadaCritical Outcome Technologies Inc.: SeeThruEquity Initiates Research CoverageTSXV:COTCotinga Pharmaceuticals Inc
13/06/201415h00MarketwiredCritical Outcome Technologies Invited to Present at 16th International p53 Workshop in SwedenTSXV:COTCotinga Pharmaceuticals Inc
04/06/201415h00MarketwiredCritical Outcome Technologies Inc. Completes FinancingTSXV:COTCotinga Pharmaceuticals Inc
27/05/201422h48Marketwired CanadaCritical Outcome Technologies Inc. Announces Warrant Term AmendmentTSXV:COTCotinga Pharmaceuticals Inc
27/05/201415h00MarketwiredCritical Outcome Technologies Selected to Present at Multiple Investor Conferences in New York CityTSXV:COTCotinga Pharmaceuticals Inc
22/05/201415h00Access WireSeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014TSXV:COTCotinga Pharmaceuticals Inc
01/05/201414h48MarketwiredFinancing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug CandidateTSXV:COTCotinga Pharmaceuticals Inc
14/04/201422h30Marketwired CanadaCritical Outcome Technologies Announces Warrant IssuanceTSXV:COTCotinga Pharmaceuticals Inc
04/04/201415h00MarketwiredCritical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian CancerTSXV:COTCotinga Pharmaceuticals Inc
14/03/201414h00MarketwiredCritical Outcome Technologies Reports Third Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
26/02/201415h29MarketwiredCritical Outcome Technologies Identifies Experienced Partner for Clinical Development of COTI-2TSXV:COTCotinga Pharmaceuticals Inc
06/02/201415h13MarketwiredCritical Outcome Technologies Completes Private PlacementTSXV:COTCotinga Pharmaceuticals Inc
05/02/201414h00Marketwired CanadaCritical Outcome Technologies Announces Engagement of Maxim Group LLCTSXV:COTCotinga Pharmaceuticals Inc
18/12/201322h48MarketwiredCritical Outcome Technologies Reports Second Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
06/12/201322h05MarketwiredCritical Outcome Technologies Awards Stock OptionsTSXV:COTCotinga Pharmaceuticals Inc
06/12/201314h47MarketwiredCritical Outcome Technologies Provides Business and Scientific Update at Annual General MeetingTSXV:COTCotinga Pharmaceuticals Inc
13/11/201314h00Marketwired CanadaCOTI-2, a P53 Dependent Treatment for Many Common Cancers, Receives Additional U.S. Patent ProtectionTSXV:COTCotinga Pharmaceuticals Inc
29/10/201321h15Marketwired CanadaCritical Outcome Technologies Announces Warrant Expiry Date AmendmentTSXV:COTCotinga Pharmaceuticals Inc
15/10/201322h30Marketwired CanadaCritical Outcome Technologies Grants Stock OptionsTSXV:COTCotinga Pharmaceuticals Inc
03/10/201315h45Marketwired CanadaCritical Outcome Technologies to Present at the 12th Annual BIO Investor ForumTSXV:COTCotinga Pharmaceuticals Inc
27/09/201322h05Marketwired CanadaCritical Outcome Technologies Reports Fiscal 2014 First Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
11/09/201322h05Marketwired CanadaCritical Outcome Technologies Announces Warrant Term AmendmentsTSXV:COTCotinga Pharmaceuticals Inc
 Showing the most relevant articles for your search:TSXV:COT

Dernières Valeurs Consultées

BOV
RAIL3
RUMO S.A ON
BOV
IBIT
iShares Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés